Market Overview

Phillips-Medisize Continues to Attract Industry Thought Leaders to Connected Health Team

Share:

Expansion of Team and Worldwide Facilities Drives Company Growth

Phillips-Medisize,
a Molex
company and global leader in the design, development and commercial
manufacturing of Connected Health solutions announced today the
expansion of its Connected Health team and its global Front-End
Innovation (FEI) footprint.

The Connected Health solutions are driven by its FEI team, which has
expanded because of increased demand for device innovation and Connected
Health services. Industry experts from leading consulting, medtech and
biopharma organizations have recently joined Phillips-Medisize's
Connected Health leadership team including Kevin Deane, former Partner
at PA Consulting, Andrew Tubb, former Director of Global Marketing at
Sanofi, Chris Conger, former VP R&D at IntriCon and Neil Williams,
Health IT expert previously at TotalMobile, Microsoft and Hospira.

"Together, we bring more than 80 years' experience across all facets of
Connected Health, from deep electronics and communications technology to
the impact of digital for our customers' global sales and marketing
plans," says Kevin Deane, VP of Front-End Innovation at
Phillips-Medisize. "To us, successful Connected Health solutions are
built on three underlying foundations: robust technology, solid business
planning and empathetic patient engagement. The mission of FEI is to
build these into all of our Connected Health projects, and to ensure our
investments in new capabilities, technologies, facilities and staff
continue to add to this picture and provide increased value to our
clients."

The FEI team works with clients to develop differentiated and
drug-specific strategies to better define clients' Connected Health
value propositions and enhance return on investment. Historically, the
Phillips-Medisize FEI team has served globally from its Cambridge, UK,
and Struer, DK, offices. Due to client demand in North America, today it
announces planned FEI additions to its Fremont, Calif., office, with
future expansions slated for its Hudson, WI office and a Massachusetts
location to be finalized later this year.

"Our FEI expansion, in terms of expertise and footprint, is key for
Phillips-Medisize. We remain committed to providing customers consistent
and reliable device innovation and Connected Health strategy consulting
— no matter where in the world they're located," said Deane. "Our goal
is to leverage innovation, development and Connected Health sources
around the world to deliver the best to our customers and, in turn,
their patients."

The Phillips-Medisize FEI team is supported by its main Global
Innovation and Development (GID) centers in Europe and the US, and a
satellite center in Suzhou, China, with targeted Connected Health and
electronics production facilities in North America, Europe, and Asia,
ensuring customers around the globe have access to industry-leading
capabilities.

About Phillips-Medisize:

Phillips-Medisize, LLC, a Molex company, is an end-to-end provider of
innovation, development, manufacturing, and post-launch services to the
pharmaceutical, diagnostics, medical device and specialty commercial
markets. Post-launch services include Connected Health app and data
services. Backed by the combined global resources of Molex and its
parent company Koch Industries, Phillips-Medisize's core advantage is
the knowledge of its people to integrate design, molding, electronics,
and automation, providing innovative, high-quality manufacturing
solutions. For more information, please visit www.phillipsmedisize.com
or www.molex.com.

View Comments and Join the Discussion!